Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome
Abstract Objectives Evaluation of the ability of estimated levels of fecal calprotectin (FCP), serum intelectin-1 (ITLN1), and C-reactive protein (CRP) to differentiate between patients with ulcerative colitis (UC) and irritable bowel syndrome (IBS). Patients Three-hundred forty-two patients were ev...
Main Authors: | Rizk Sayad R. Sarhan, Yasmin M. Marei, Yomna M. Marei |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-11-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-023-00263-8 |
Similar Items
-
Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
by: von Arnim U, et al.
Published: (2016-04-01) -
Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
by: Hamid Kalantari, et al.
Published: (2015-01-01) -
Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01) -
Fecal calprotectin concentration in the differential diagnosis of bowel diseases
by: M F Osipenko, et al.
Published: (2015-02-01) -
Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series
by: Roberto Trasolini, et al.
Published: (2022-01-01)